STACEY KREHER: Open Payments
NPI 1669762902 · BAY ST. LOUIS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,364 in 32 payments from 10 companies in 2025. Trend: 2023 $7,741 · 2024 $1,563 · 2025 $7,364
Speaker / faculty: $6,989Food & beverage: $375
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 11 | $7,019 |
| Astellas Pharma US Inc | 4 | $90 |
| MAYNE PHARMA COMMERCIAL LLC | 8 | $86 |
| ABBVIE INC. | 2 | $34 |
| Sumitomo Pharma America, Inc. | 2 | $30 |
| Sage Therapeutics, LLC | 1 | $28 |
| MILLICENT US INC | 1 | $22 |
| Abbott Laboratories | 1 | $21 |
| PFIZER INC. | 1 | $18 |
| Hologic Sales and Service, LLC | 1 | $17 |
Products named: NEXPLANON, Veozah, VRAYLAR, MYFEMBREE, ZURZUVAE, INTRAROSA, FREESTYLE LIBRE 3, ABRYSVO.
Industry payments across MS — which companies pay providers there.
